Galen W Stahle, MD in Deephaven, MN - Psychiatry & Neurology

Galen W Stahle, MD is a Psychiatry & Neurology - Psychiatry physician based in Deephaven, Minnesota. Galen W Stahle is licensed to practice in Minnesota (license number 23848) and his current practice location is 18300 Mtka Blvd., Ste 210, Deephaven, Minnesota. He can be reached at his office (for appointments etc.) via phone at (952) 404-9124.

NPI number for Galen W Stahle is 1790846442 and his current mailing address is 18300 Mtka Blvd., Ste 210, Deephaven, Minnesota. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1790846442.

Contact Information

	Galen W Stahle, MD
	18300 Mtka Blvd., Ste 210, Deephaven, MN 55391-3272
	(952) 404-9124
	(952) 404-9273

Physician's Profile

Full Name	Galen W Stahle
Gender	Male
Speciality	Psychiatry & Neurology - Psychiatry
Location	18300 Mtka Blvd., Ste 210, Deephaven, Minnesota
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1790846442
Provider Enumeration Date: 12/13/2006
Last Update Date: 07/09/2007

Medical Identifiers

Medical identifiers for Galen W Stahle such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1790846442	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
2084P0800X	Psychiatry & Neurology - Psychiatry	23848 (Minnesota)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Galen W Stahle is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Galen W Stahle, MD 18300 Mtka Blvd., Ste 210, Deephaven, MN 55391-3272 Ph: (952) 404-9124	Galen W Stahle, MD 18300 Mtka Blvd., Ste 210, Deephaven, MN 55391-3272 Ph: (952) 404-9124

News Archive

UAB reaction to Lancet study on human papilloma virus (HPV)

The prominent British medical journal Lancet published results of a clinical trial on a vaccine for human papilloma virus (HPV) The virus is a leading cause of cervical cancer and genital warts.

HRT not such a bad idea after all!

Older women struggling to cope with the symptoms of the menopause will be reassured by the latest research into hormone replacement therapy (HRT).

3SBio enters into exclusive license agreement with PharmAbcine for Tanibirumab

3SBio Inc., a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, today announced it has entered into an exclusive license with PharmAbcine, Inc. for the development, manufacturing and marketing of Tanibirumab, an anti-VEGFR2/KDR antibody for cancer in the territory of Greater China (including Mainland China, Taiwan, Hong Kong and Macau) and several emerging countries, including Thailand, Brazil and Russia.

Specialists in infectious disease and global health convene at Philadelphia meeting

Nearly 2,500 physicians and scientists from institutions around the world such as the World Health Organization, the Centers for Disease Control and the National Institutes of Health will meet at the 56th American Society of Tropical Medicine and Hygiene's Annual Meeting on Nov. 4-8, in Philadelphia to discuss the latest research on infectious diseases and bioterrorist and global health threats.

The U.S. can erase cervical cancer in two decades

Cervical cancer is preventable, thanks to the development of the human papillomavirus (HPV) vaccine. Various strains of HPV, a sexually transmitted infection, play a significant role in the event of cervical cancer. Now, the U.S. can eradicate cervical cancer within the next 20 years, according to a new study.

Galen W Stahle, MD - Psychiatry & Neurology in Deephaven, MN